Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 149 entries
Sorted by: Best Match Show Resources per page
Readers' responses to the webcast video editorial entitled "how to take useful drugs without hurting yourself".

MedGenMed : Medscape general medicine

Ernsberger P.
PMID: 16385720
MedGenMed. 2005;7(2):38.

No abstract available.

Cite
Ernsberger P. Readers' responses to the webcast video editorial entitled "how to take useful drugs without hurting yourself". MedGenMed. 2005;7(2):38
Ernsberger, P. (2005). Readers' responses to the webcast video editorial entitled "how to take useful drugs without hurting yourself". MedGenMed : Medscape general medicine, 7(2), 38.
Ernsberger, Paul. "Readers' responses to the webcast video editorial entitled "how to take useful drugs without hurting yourself"." MedGenMed : Medscape general medicine vol. 7,2 (2005): 38.
Ernsberger P. Readers' responses to the webcast video editorial entitled "how to take useful drugs without hurting yourself". MedGenMed. 2005;7(2):38. PMID: 16385720.
Copy Download .nbib Format: NLM
Treatment of type 2 diabetes mellitus. Introduction.

Diabetes research and clinical practice

Shafrir E, Malecki M, Schernthaner G, Kiljanski J.
PMID: 19019474
Diabetes Res Clin Pract. 2008 Dec 15;82:S81-2. doi: 10.1016/j.diabres.2008.09.019. Epub 2008 Nov 18.

No abstract available.

Cite
Shafrir E, Malecki M, Schernthaner G, et al. Treatment of type 2 diabetes mellitus. Introduction. Diabetes Res Clin Pract. 2008;82:S81-2doi: 10.1016/j.diabres.2008.09.019.
Shafrir, E., Malecki, M., Schernthaner, G., & Kiljanski, J. (2008). Treatment of type 2 diabetes mellitus. Introduction. Diabetes research and clinical practice, 82S81-2. https://doi.org/10.1016/j.diabres.2008.09.019
Shafrir, Eleazar, et al. "Treatment of type 2 diabetes mellitus. Introduction." Diabetes research and clinical practice vol. 82 (2008): S81-2. doi: https://doi.org/10.1016/j.diabres.2008.09.019
Shafrir E, Malecki M, Schernthaner G, Kiljanski J. Treatment of type 2 diabetes mellitus. Introduction. Diabetes Res Clin Pract. 2008 Dec 15;82:S81-2. doi: 10.1016/j.diabres.2008.09.019. Epub 2008 Nov 18. PMID: 19019474.
Copy Download .nbib Format: NLM
[Comprehensive review of type 2 diabetes treatment in primary health care. Hygienic, dietetic, educational and pharmacological aspects].

Enfermeria clinica

Fernández-Duque MV, Maciá-Bobes C, Prida-Villa E, Ronzón-Fernández A.
PMID: 18218266
Enferm Clin. 2008 Jan-Feb;18(1):41-5. doi: 10.1016/s1130-8621(08)70692-2.

Type 2 diabetes is a highly prevalent disease and its management is performed mainly in primary health care. In the present article, focused on the nursing point of view, we propose a comprehensive and very simple approach to the...

Cite
Fernández-Duque MV, Maciá-Bobes C, Prida-Villa E, et al. Revisión integral del tratamiento de la diabetes tipo 2 en atención primaria. Aspectos higienicodietéticos, educacionales y farmacológicos. [Comprehensive review of type 2 diabetes treatment in primary health care. Hygienic, dietetic, educational and pharmacological aspects]. Enferm Clin. 2008;18(1):41-5doi: 10.1016/s1130-8621(08)70692-2.
Fernández-Duque, M. V., Maciá-Bobes, C., Prida-Villa, E., & Ronzón-Fernández, A. (2008). Revisión integral del tratamiento de la diabetes tipo 2 en atención primaria. Aspectos higienicodietéticos, educacionales y farmacológicos. [Comprehensive review of type 2 diabetes treatment in primary health care. Hygienic, dietetic, educational and pharmacological aspects]. Enfermeria clinica, 18(1), 41-5. https://doi.org/10.1016/s1130-8621(08)70692-2
Fernández-Duque, María Violeta, et al. "Revisión integral del tratamiento de la diabetes tipo 2 en atención primaria. Aspectos higienicodietéticos, educacionales y farmacológicos." [Comprehensive review of type 2 diabetes treatment in primary health care. Hygienic, dietetic, educational and pharmacological aspects]. Enfermeria clinica vol. 18,1 (2008): 41-5. doi: https://doi.org/10.1016/s1130-8621(08)70692-2
Fernández-Duque MV, Maciá-Bobes C, Prida-Villa E, Ronzón-Fernández A. Revisión integral del tratamiento de la diabetes tipo 2 en atención primaria. Aspectos higienicodietéticos, educacionales y farmacológicos. [Comprehensive review of type 2 diabetes treatment in primary health care. Hygienic, dietetic, educational and pharmacological aspects]. Enferm Clin. 2008 Jan-Feb;18(1):41-5. doi: 10.1016/s1130-8621(08)70692-2. Spanish. PMID: 18218266.
Copy Download .nbib Format: NLM
[Professor Zhang Zhi-long's experience in the treatment for type 2 diabetes mellitus and its complications].

Zhongguo zhen jiu = Chinese acupuncture & moxibustion

Chen H.
PMID: 20942282
Zhongguo Zhen Jiu. 2010 Aug;30(8):653-6.

This paper summarizes professor ZHANG Zhi-long's academic thoughts and his specialized treatment experience for type 2 diabetes mellitus and its complications. There are three aspects: emphasizes the importance of scientific investigation and the classics in TCM, states that spleen...

Cite
Chen H. [Professor Zhang Zhi-long's experience in the treatment for type 2 diabetes mellitus and its complications]. Zhongguo Zhen Jiu. 2010;30(8):653-6
Chen, H. (2010). [Professor Zhang Zhi-long's experience in the treatment for type 2 diabetes mellitus and its complications]. Zhongguo zhen jiu = Chinese acupuncture & moxibustion, 30(8), 653-6.
Chen, Hong. "[Professor Zhang Zhi-long's experience in the treatment for type 2 diabetes mellitus and its complications]." Zhongguo zhen jiu = Chinese acupuncture & moxibustion vol. 30,8 (2010): 653-6.
Chen H. [Professor Zhang Zhi-long's experience in the treatment for type 2 diabetes mellitus and its complications]. Zhongguo Zhen Jiu. 2010 Aug;30(8):653-6. Chinese. PMID: 20942282.
Copy Download .nbib Format: NLM
Novel treatments for type 2 diabetes.

The British journal of general practice : the journal of the Royal College of General Practitioners

Seewoodhary J, Bain SC.
PMID: 21401982
Br J Gen Pract. 2011 Jan;61(582):5-6. doi: 10.3399/bjgp11X548884.

No abstract available.

Cite
Seewoodhary J, Bain SC. Novel treatments for type 2 diabetes. Br J Gen Pract. 2011;61(582):5-6doi: 10.3399/bjgp11X548884.
Seewoodhary, J., & Bain, S. C. (2011). Novel treatments for type 2 diabetes. The British journal of general practice : the journal of the Royal College of General Practitioners, 61(582), 5-6. https://doi.org/10.3399/bjgp11X548884
Seewoodhary, Jason, and Bain, Stephen C. "Novel treatments for type 2 diabetes." The British journal of general practice : the journal of the Royal College of General Practitioners vol. 61,582 (2011): 5-6. doi: https://doi.org/10.3399/bjgp11X548884
Seewoodhary J, Bain SC. Novel treatments for type 2 diabetes. Br J Gen Pract. 2011 Jan;61(582):5-6. doi: 10.3399/bjgp11X548884. PMID: 21401982; PMCID: PMC3020044.
Copy Download .nbib Format: NLM
[Gliptines: a new fashion?].

La Revue du praticien

Scheen AJ.
PMID: 23687746
Rev Prat. 2013 Mar;63(3):304-5.

No abstract available.

Cite
Scheen AJ. Les gliptines, une nouvelle mode? [Gliptines: a new fashion?]. Rev Prat. 2013;63(3):304-5
Scheen, A. J. (2013). Les gliptines, une nouvelle mode? [Gliptines: a new fashion?]. La Revue du praticien, 63(3), 304-5.
Scheen, André J. "Les gliptines, une nouvelle mode?" [Gliptines: a new fashion?]. La Revue du praticien vol. 63,3 (2013): 304-5.
Scheen AJ. Les gliptines, une nouvelle mode? [Gliptines: a new fashion?]. Rev Prat. 2013 Mar;63(3):304-5. French. PMID: 23687746.
Copy Download .nbib Format: NLM
Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus.

BMC medicine

Nisal K, Kela R, Khunti K, Davies MJ.
PMID: 23198896
BMC Med. 2012 Nov 30;10:152. doi: 10.1186/1741-7015-10-152.

Type 2 diabetes mellitus is widely prevalent and is often coexistent with obesity. Many of the available treatment options have side effects such as weight gain which often affect patient's willingness to continue the treatment. Effective weight loss, lack...

Cite
Nisal K, Kela R, Khunti K, et al. Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus. BMC Med. 2012;10:152doi: 10.1186/1741-7015-10-152.
Nisal, K., Kela, R., Khunti, K., & Davies, M. J. (2012). Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus. BMC medicine, 10152. https://doi.org/10.1186/1741-7015-10-152
Nisal, Kaustubh, et al. "Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus." BMC medicine vol. 10 (2012): 152. doi: https://doi.org/10.1186/1741-7015-10-152
Nisal K, Kela R, Khunti K, Davies MJ. Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus. BMC Med. 2012 Nov 30;10:152. doi: 10.1186/1741-7015-10-152. PMID: 23198896; PMCID: PMC3599222.
Copy Download .nbib Format: NLM
Introduction: Evaluating the role of incretin-based therapies in the management of type 2 diabetes.

The American journal of managed care

[No authors listed]
PMID: 21528614
Am J Manag Care. 2011 Mar;17(2):S39-40.

No abstract available.

Cite
Introduction: Evaluating the role of incretin-based therapies in the management of type 2 diabetes. Am J Manag Care. 2011;17(2):S39-40
(2011). Introduction: Evaluating the role of incretin-based therapies in the management of type 2 diabetes. The American journal of managed care, 17(2), S39-40.
"Introduction: Evaluating the role of incretin-based therapies in the management of type 2 diabetes." The American journal of managed care vol. 17,2 (2011): S39-40.
Introduction: Evaluating the role of incretin-based therapies in the management of type 2 diabetes. Am J Manag Care. 2011 Mar;17(2):S39-40. PMID: 21528614.
Copy Download .nbib Format: NLM
Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformatics.

Drug design, development and therapy

Liu L, Ma Y, Wang RL, Xu WR, Wang SQ, Chou KC.
PMID: 23630413
Drug Des Devel Ther. 2013 Apr 08;7:279-88. doi: 10.2147/DDDT.S42113. Print 2013.

The high prevalence of type 2 diabetes mellitus in the world as well as the increasing reports about the adverse side effects of the existing diabetes treatment drugs have made developing new and effective drugs against the disease a...

Cite
Liu L, Ma Y, Wang RL, et al. Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformatics. Drug Des Devel Ther. 2013;7:279-88doi: 10.2147/DDDT.S42113.
Liu, L., Ma, Y., Wang, R. L., Xu, W. R., Wang, S. Q., & Chou, K. C. (2013). Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformatics. Drug design, development and therapy, 7279-88. https://doi.org/10.2147/DDDT.S42113
Liu, Lei, et al. "Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformatics." Drug design, development and therapy vol. 7 (2013): 279-88. doi: https://doi.org/10.2147/DDDT.S42113
Liu L, Ma Y, Wang RL, Xu WR, Wang SQ, Chou KC. Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformatics. Drug Des Devel Ther. 2013 Apr 08;7:279-88. doi: 10.2147/DDDT.S42113. Print 2013. PMID: 23630413; PMCID: PMC3623550.
Copy Download .nbib Format: NLM
Re: Leiter LA, Berard L, Bowering CK, et al. Type 2 Diabetes mellitus management in Canada: is it improving? Can J Diabetes 37;2:82-9.

Canadian journal of diabetes

Halperin IJ, Ivers NM, Wong R.
PMID: 24070882
Can J Diabetes. 2013 Aug;37(4):213. doi: 10.1016/j.jcjd.2013.06.003. Epub 2013 Aug 02.

No abstract available.

Cite
Halperin IJ, Ivers NM, Wong R. Re: Leiter LA, Berard L, Bowering CK, et al. Type 2 Diabetes mellitus management in Canada: is it improving? Can J Diabetes 37;2:82-9. Can J Diabetes. 2013;37(4):213doi: 10.1016/j.jcjd.2013.06.003.
Halperin, I. J., Ivers, N. M., & Wong, R. (2013). Re: Leiter LA, Berard L, Bowering CK, et al. Type 2 Diabetes mellitus management in Canada: is it improving? Can J Diabetes 37;2:82-9. Canadian journal of diabetes, 37(4), 213. https://doi.org/10.1016/j.jcjd.2013.06.003
Halperin, Ilana J, et al. "Re: Leiter LA, Berard L, Bowering CK, et al. Type 2 Diabetes mellitus management in Canada: is it improving? Can J Diabetes 37;2:82-9." Canadian journal of diabetes vol. 37,4 (2013): 213. doi: https://doi.org/10.1016/j.jcjd.2013.06.003
Halperin IJ, Ivers NM, Wong R. Re: Leiter LA, Berard L, Bowering CK, et al. Type 2 Diabetes mellitus management in Canada: is it improving? Can J Diabetes 37;2:82-9. Can J Diabetes. 2013 Aug;37(4):213. doi: 10.1016/j.jcjd.2013.06.003. Epub 2013 Aug 02. PMID: 24070882.
Copy Download .nbib Format: NLM
Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention.

International journal of medical sciences

Wu Y, Ding Y, Tanaka Y, Zhang W.
PMID: 25249787
Int J Med Sci. 2014 Sep 06;11(11):1185-200. doi: 10.7150/ijms.10001. eCollection 2014.

Type 2 diabetes is a serious and common chronic disease resulting from a complex inheritance-environment interaction along with other risk factors such as obesity and sedentary lifestyle. Type 2 diabetes and its complications constitute a major worldwide public health...

Cite
Wu Y, Ding Y, Tanaka Y, et al. Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. Int J Med Sci. 2014;11(11):1185-200doi: 10.7150/ijms.10001.
Wu, Y., Ding, Y., Tanaka, Y., & Zhang, W. (2014). Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. International journal of medical sciences, 11(11), 1185-200. https://doi.org/10.7150/ijms.10001
Wu, Yanling, et al. "Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention." International journal of medical sciences vol. 11,11 (2014): 1185-200. doi: https://doi.org/10.7150/ijms.10001
Wu Y, Ding Y, Tanaka Y, Zhang W. Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. Int J Med Sci. 2014 Sep 06;11(11):1185-200. doi: 10.7150/ijms.10001. eCollection 2014. PMID: 25249787; PMCID: PMC4166864.
Copy Download .nbib Format: NLM
The clinical burden of type 2 diabetes in patients with acute coronary syndromes: prognosis and implications for short- and long-term management.

Diabetes & vascular disease research

Katz P, Leiter LA, Mellbin L, Rydén L.
PMID: 25187508
Diab Vasc Dis Res. 2014 Nov;11(6):395-409. doi: 10.1177/1479164114546854. Epub 2014 Sep 03.

Type 2 diabetes mellitus (T2DM) is associated with increased morbidity and mortality in patients with acute coronary syndromes (ACS). Cardiometabolic risk factors, including hyperglycaemia, insulin resistance, atherogenic dyslipidaemia, increased visceral fat and inflammation, are associated with increased risk in...

Cite
Katz P, Leiter LA, Mellbin L, et al. The clinical burden of type 2 diabetes in patients with acute coronary syndromes: prognosis and implications for short- and long-term management. Diab Vasc Dis Res. 2014;11(6):395-409doi: 10.1177/1479164114546854.
Katz, P., Leiter, L. A., Mellbin, L., & Rydén, L. (2014). The clinical burden of type 2 diabetes in patients with acute coronary syndromes: prognosis and implications for short- and long-term management. Diabetes & vascular disease research, 11(6), 395-409. https://doi.org/10.1177/1479164114546854
Katz, Pamela, et al. "The clinical burden of type 2 diabetes in patients with acute coronary syndromes: prognosis and implications for short- and long-term management." Diabetes & vascular disease research vol. 11,6 (2014): 395-409. doi: https://doi.org/10.1177/1479164114546854
Katz P, Leiter LA, Mellbin L, Rydén L. The clinical burden of type 2 diabetes in patients with acute coronary syndromes: prognosis and implications for short- and long-term management. Diab Vasc Dis Res. 2014 Nov;11(6):395-409. doi: 10.1177/1479164114546854. Epub 2014 Sep 03. PMID: 25187508.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 149 entries